-
Vanarix
Created in 2018
-
-
Up & running (A)
Existing signals show a regular activity -
Social networks
1,055 -
Activities
-
Technologies
-
Entity types
-
Location
Av. Mon-Repos 14, 1005 Lausanne, Switzerland
Lausanne
Switzerland
-
Employees
Scale: 2-10
Estimated: 6
-
Engaged catalyst
1
0 0 -
Added in Motherbase
2 years, 1 month ago
-
Value proposition
We developed a new generation of cell therapy products to regenerate articular cartilage damage: Cartibeads
Vanarix has developed a new generation of cell therapy to produce high-quality hyaline cartilage mini-grafts, named Cartibeads, which resemble native tissue. Cartibeads are bio-engineered cartilage implant made from allogeneic chondrocytes.
When implanted during minimally invasive arthroscopic surgery, Cartibeads can completely self-integrate into cartilage lesions and thus regenerate the tissue. Cartibeads are designed for the treatment of cartilage defects in traumatic and osteoarthritic joints.
#cartilagerepair
#cartilageregeneration
#celltherapy
#kneerepair
#osteoarthritis
-
Cartibeads bio-engineered cartilage grafts
Vanarix develops cartilage regeneration, the first autologous hyaline cartilage microtissues of high quality, designed for everyone whatever your age. We offer a new technology to treat cartilage lesions. We have developed and recently patented a method for the production of Cartibeads
https://www.vanarix-cartilage-regeneration.ch/
